142 related articles for article (PubMed ID: 11950701)
21. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
22. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
23. Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures.
Axel DI; Riessen R; Runge H; Viebahn R; Karsch KR
J Cardiovasc Pharmacol; 2000 Apr; 35(4):619-29. PubMed ID: 10774794
[TBL] [Abstract][Full Text] [Related]
24. Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi.
Cazzola M; Calzetta L; Page CP; Rinaldi B; Capuano A; Matera MG
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):704-10. PubMed ID: 21278325
[TBL] [Abstract][Full Text] [Related]
25. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
[TBL] [Abstract][Full Text] [Related]
26. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
28. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
[TBL] [Abstract][Full Text] [Related]
30. Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production.
Davis ME; Harrison DG
Circulation; 2001 Jan; 103(1):2-4. PubMed ID: 11136674
[No Abstract] [Full Text] [Related]
31. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis.
Ganné F; Vasse M; Beaudeux JL; Peynet J; François A; Mishal Z; Chartier A; Tobelem G; Vannier JP; Soria J; Soria C
Thromb Haemost; 2000 Oct; 84(4):680-8. PubMed ID: 11057870
[TBL] [Abstract][Full Text] [Related]
32. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
Tsunekawa T; Hayashi T; Kano H; Sumi D; Matsui-Hirai H; Thakur NK; Egashira K; Iguchi A
Circulation; 2001 Jul; 104(4):376-9. PubMed ID: 11468195
[TBL] [Abstract][Full Text] [Related]
33. The effects of different types of statins on proliferation and migration of HGF-induced Human Umbilical Vein Endothelial Cells (HUVECs).
Burgazli KM; Bui KL; Mericliler M; Albayrak AT; Parahuleva M; Erdogan A
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2874-83. PubMed ID: 24254555
[TBL] [Abstract][Full Text] [Related]
34. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC.
Takeuchi S; Kawashima S; Rikitake Y; Ueyama T; Inoue N; Hirata K; Yokoyama M
Biochem Biophys Res Commun; 2000 Mar; 269(1):97-102. PubMed ID: 10694484
[TBL] [Abstract][Full Text] [Related]
35. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.
Aikawa M; Rabkin E; Sugiyama S; Voglic SJ; Fukumoto Y; Furukawa Y; Shiomi M; Schoen FJ; Libby P
Circulation; 2001 Jan; 103(2):276-83. PubMed ID: 11208689
[TBL] [Abstract][Full Text] [Related]
36. HMG-CoA reductase inhibitor cerivastatin inhibits interleukin-6 expression and secretion in human adipocytes.
van Harmelen V; Skurk T; Röhrig K; Hauner H
Horm Metab Res; 2003 Aug; 35(8):466-70. PubMed ID: 12953163
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
Okamoto T; Yamagishi S; Inagaki Y; Amano S; Koga K; Abe R; Takeuchi M; Ohno S; Yoshimura A; Makita Z
FASEB J; 2002 Dec; 16(14):1928-30. PubMed ID: 12368225
[TBL] [Abstract][Full Text] [Related]
39. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
40. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
